| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.005 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.005 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |